S

Shanghai Wanye Enterprises Co Ltd
SSE:600641

Watchlist Manager
Shanghai Wanye Enterprises Co Ltd
SSE:600641
Watchlist
Price: 15.66 CNY -2.43% Market Closed
Market Cap: 14.3B CNY
Have any thoughts about
Shanghai Wanye Enterprises Co Ltd?
Write Note

Net Margin
Shanghai Wanye Enterprises Co Ltd

-8.7%
Current
25%
Average
7.8%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-8.7%
=
Net Income
-44.1m
/
Revenue
510.3m

Net Margin Across Competitors

Country CN
Market Cap 14.5B CNY
Net Margin
-9%
Country HK
Market Cap 160.8B HKD
Net Margin
11%
Country HK
Market Cap 134.8B HKD
Net Margin
11%
Country IN
Market Cap 1.4T INR
Net Margin
17%
Country CN
Market Cap 109.5B CNY
Net Margin
2%
Country HK
Market Cap 112.1B HKD
Net Margin
22%
Country HK
Market Cap 109.2B HKD
Net Margin
35%
Country CN
Market Cap 96.8B CNY
Net Margin
2%
Country CN
Market Cap 90.9B CNY
Net Margin
-5%
Country IN
Market Cap 822.1B INR
Net Margin
46%
Country IN
Market Cap 803.7B INR
Net Margin
39%
No Stocks Found

Shanghai Wanye Enterprises Co Ltd
Glance View

Market Cap
14.5B CNY
Industry
Real Estate

Shanghai Wanye Enterprises Co Ltd has traversed an intriguing journey from its origins, evolving into a dynamic player in several sectors. Rooted in the bustling metropolis of Shanghai, the company navigates multiple industries with a focus on real estate, biotechnology, and high-tech investments. Over the years, Wanye has astutely recognized the potential in blending traditional real estate ventures with new-age biotech innovations. Its real estate arm concentrates primarily on the development and management of commercial and residential properties, leveraging its deep understanding of urban landscapes to maximize asset value. Meanwhile, its interest in biotechnology represents a strategic pivot towards high-growth sectors, signifying an alignment with global trends in health and science innovations. Money-making for Wanye Enterprises involves a sophisticated balance of developing high-demand real estate projects and acquiring stakes in promising biotech start-ups and technological ventures. This dual approach not only diversifies its revenue streams but also mitigates risks associated with market fluctuations in single sectors. The company's real estate segment generates consistent cash flow through property sales and rental income, underwriting its forays into the less predictable biotech sector. Meanwhile, investments in technology and biotechnology hold the potential for substantial returns, underpinning growth through innovations that could revolutionize industries. Through strategic investment, development expertise, and market adaptability, Shanghai Wanye Enterprises Co Ltd effectively harnesses various economic waves, positioning itself as a resilient business entity in China's rapidly evolving economic landscape.

Intrinsic Value
8.34 CNY
Overvaluation 47%
Intrinsic Value
Price
S

See Also

Discover More
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-8.7%
=
Net Income
-44.1m
/
Revenue
510.3m
What is the Net Margin of Shanghai Wanye Enterprises Co Ltd?

Based on Shanghai Wanye Enterprises Co Ltd's most recent financial statements, the company has Net Margin of -8.7%.